Lerzeparib
Lerzeparib is an (ADP-ribose) polymerase (PARP) inhibitor, with antineoplastic activity[1].
Product Specifications
CAS Number
2459693-01-5
UNSPSC
12352005
Target
PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lerzeparib.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C3C(CON1)=C(C4=CC=C([C@]5(CCCN5)C)C=C4)NC3=CC(F)=C2
Molecular Formula
C21H20FN3O2
Molecular Weight
365.40
References & Citations
[1]Hu Yanbin, et al. Indolo heptamyl oxime analogue as PARP inhibitor. World Intellectual Property Organization, WO2020156577 A1. 2020-08-06.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP309563 20 µg
GRP94 (HSP90B1) (NM_003299) Human Recombinant Protein
Sign In for Pricing
View Details ![SIGLEC15 Mouse Monoclonal Antibody [Clone ID: OTI11G6]](https://cdn.genprice.uk/products/937/68dd18bc061270361e90919a/imageurl/cf815410.webp)
CF815410 100 µg
SIGLEC15 Mouse Monoclonal Antibody [Clone ID: OTI11G6]
Sign In for Pricing
View Details 
